Skip to main content

Orthopaedic Surgery receives over $2.2 million in research funding from defense department

 The three-year study will investigate why prostate cancer often spreads to the bones, and whether weakened bones — due to age, fractures or hormone treatment — make patients more vulnerable to this deadly progression.



Prostate cancer is the second leading cause of cancer death in men, with one in 44 American men dying from the disease. While cancer is usually diagnosed after age 65, most lab-based research does not reflect the bone health challenges of older adults.

Military veterans have higher rates of prostate cancer and bone injuries

A major contributor to bone loss in prostate cancer patients is androgen deprivation therapy (ADT), a common treatment that lowers testosterone levels but also weakens bones. Yet only a small fraction of men receiving this therapy undergo bone density screening, even though the risk of fracture and osteoporosis is high. This is particularly high among military veterans, who have double the rate of prostate cancer compared to civilians and face a higher risk of bone injuries.

The team plans to use mouse models that better reflect the aging human skeleton. It will test whether restoring bone density with an FDA-approved drug called romosozumab (Evenity) can prevent or slow the spread of cancer to the bones. Romosozumab is currently used to treat osteoporosis in women by stimulating new bone growth.

“If this drug can be shown to not only rebuild bone but also reduce cancer spread, it could be quickly repurposed for prostate cancer patients,” Loots explained.

This research could lead to a new approach in prostate cancer care — one that factors in bone health as a major contributor to cancer progression and uses bone-targeted therapies to protect patients from the deadliest stages of the disease.

“We are very pleased to see the recognition of this outstanding team science led by Dr. Loots,” said R. Lor Randall orthopaedic surgery chair and holder of the David Linn Endowed Chair in orthopaedic surgery. “Cancer related involvement of the skeleton makes up about 20% of the cancer care economy in the US. This project is a major step forward in helping address the medical and socioeconomic suffering of so many.”Exploring joint damage and how it could be reversed to prevent arthritis

The second federal grant, for $442,750, is directed to the Department of Orthopaedic Surgery to investigate a little-known biological process that could help prevent post-traumatic osteoarthritis (PTOA). The painful and often disabling condition commonly develops after joint injuries such as torn ACLs or meniscus tears.

If successful, the two-year study could pave the way for new drug treatments that prevent arthritis from developing after traumatic joint injuries — a breakthrough especially important for military service members, who experience a higher rate of orthopaedic injuries.

Loots is also the lead investigator on this study, along with her colleague, co-investigator Blaine Christiansen, another professor in the Department of Orthopaedic Surgery.

“This research could have real implications for improving the quality of life for injured veterans and active-duty soldiers,” Loots said. “It’s about giving doctors tools to protect joint health before arthritis takes hold.”Key cellular process may be to blame

The team is exploring how a recently discovered cellular process called lactylation may be at least partly to blame for joint damage and arthritis pain following injury.

Using advanced protein analysis techniques and genetically modified mice, the team will examine whether blocking the production of lactate — a compound tied to this process — can reduce joint damage and pain.

If lactylation is confirmed to be a key contributor, it could open the door to new therapies that stop arthritis before it starts.

“Right now, we have no drugs that can prevent or reverse joint damage once osteoarthritis sets in,” Loots said. “But post-traumatic arthritis gives us a unique window to intervene early — even at the time of surgery or shortly after injury.”

Website: cognitivescientist.org 



Comments

Post a Comment

Popular posts from this blog

As fewer Americans die from heart attacks, more succumb to chronic heart disease

Image
  From 1970 to 2022, deaths from heart attacks dropped by almost 90%, but more Americans now die from other types of heart disease, Stanford Medicine-led research has found. In 1970, someone over the age of 65 hospitalized for a heart attack in the United States had about a 60% chance of leaving the hospital alive. Today, the survival rate is over 90%, with even better outcomes for younger patients. Those numbers have contributed to a remarkable decrease in the likelihood of dying from any type of heart disease over the last 50 years, according to a new study of heart disease mortality led by Stanford Medicine researchers. In 1970, 41% of all deaths were attributed to ailments of the heart; in 2022, that statistic had dropped to 24% of all deaths.  Most strikingly, the proportion of deaths from acute myocardial infarctions — commonly known as heart attacks — fell nearly 90% during that period. The decrease is a testament to the leaps and bounds made in our ability to manage an...
Read more

Impact of Sleep Disorders and Disturbed Sleep on Brain Health: A Scientific Statement From the American Heart Association

Image
  Accumulating evidence supports a link between sleep disorders, disturbed sleep, and adverse brain health, ranging from stroke to subclinical cerebrovascular disease to cognitive outcomes, including the development of Alzheimer disease and Alzheimer disease–related dementias. Sleep disorders such as sleep-disordered breathing (eg, obstructive sleep apnea), and other sleep disturbances, as well, some of which are also considered sleep disorders (eg, insomnia, sleep fragmentation, circadian rhythm disorders, and extreme sleep duration), have been associated with adverse brain health.  Understanding the causal role of sleep disorders and disturbances in the development of adverse brain health is complicated by the common development of sleep disorders among individuals with neurodegenerative disease. In addition to the role of sleep disorders in stroke and cerebrovascular injury, mechanistic hypotheses linking sleep with brain health and biomarker data (blood-based, cerebrospina...
Read more

Cycling Boosts Brain Function in Parkinson’s Disease

Image
A novel study conducted at University Hospitals and the VA Northeast Ohio Healthcare System, through its Cleveland Functional Electrical Stimulation (FES) Center, provides clues, as it shows that long-term dynamic exercise programs might have wider restorative effects on the brain signals of Parkinson’s Disease (PD) patients than researchers previously thought. Researchers used recordings from participants’ deep brain stimulation devices to try to assess how long-term exercise programs might be re-activating connections damaged by Parkinson’s Disease. Unlike previous studies, this investigation sought to decode the brain changes linked to motor symptom relief; both with the help of second-generation DBS devices and a long-term dynamic cycling exercise regimen in Parkinson’s patients. Details on the study are published in the June 2025 issue of  Clinical Neurophysiology . The pilot investigation, funded by a VA Merit Award from the Department of Veterans Affairs along with philanthr...
Read more